Furthermore, the tight association between these two classes of mediators (OP-1 and IL-6) was documented under both experimental conditions (plus or minus OP-1).
The results of this analysis indicate five classes of mediators capable of tuning the development of the interaction process according to the context and emotional state of the participants.
The principal aim was to establish the correlations which may exist among the different classes of mediators and aging with the hypothesis that the oral cavity may be in a state of low chronic inflammation.
Another objective is to assess whether or not the combined use of antagonists to the three classes of mediators could result in a stronger inhibitory effect on neutrophil trafficking.
Release of individual prostanoids, HETEs, and LTB4 over the course of transient synovitis did not reveal marked temporal differences between these classes of mediators, although there was a trend toward early response of prostanoids versus a somewhat more protracted response of HETEs and LTB4.
Researchers have recently described that the two main active fish oil pharmaconutrients, EPA and docosahexaenoic acid, are substrates of two novel classes of mediators called resolvins and protectins [ 11, 12], which are involved in the resolution of the inflammatory process [ 13- 15].
It concerns both classes of TEs.
AnxA1 is the prototype of a new class of mediators able to potently modulate both the innate and adaptive immune response; while effecting inhibitory properties on inflammatory cells, setting in motion pro-resolving responses, this protein acts as a positive relay in T cell activation.
A second class of mediators that affect insulin sensitivity in both muscle and liver and which are derived from adipose tissue are adipokines.
The SDF-1α/CXCR4 axis belongs to this class of mediators and recent studies have shown that inhibition of CXCR4 with antibodies, peptide antagonists or siRNA all reduce metastasis in several solid tumors, including breast [8], [36], [37], [38], melanoma [12], [39], pancreas [40], prostate [41] and colon [42] cancers.
